Reserved for VANFLYTA® (quizartinib)

50% off the $29.99 Custom Kit. Use at checkout:

HCPTREATINGA50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

VANFLYTA® (quizartinib)

VANFLYTA® (quizartinib)

Unclaimed

AEO Score: 4/10

Monitoring for AI engine activity

In the Engagemii AEO index

#296,898 of 455,797 in Healthcare for AI visibility

hcp-treating-aml.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. VANFLYTA® (quizartinib) just got measured.

4/10 means VANFLYTA® (quizartinib) is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About VANFLYTA® (quizartinib)

Discover VANFLYTA® (quizartinib) for treatment-eligible patients with newly diagnosed FLT3-ITD+ AML. See Prescribing Info & Boxed WARNINGS.

Details

Industry: Healthcare

hcp-treating-aml.com

AI Visibility Breakdown

2

Structured Data

4

Content Structure

7

Entity Clarity

5

E-E-A-T Signals

6

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for VANFLYTA® (quizartinib): Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for VANFLYTA® (quizartinib).

Source & Attribution

Scored by Engagemii on July 11, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/hcp-treating-aml

Cite this score: Engagemii (2026). "AEO Score for VANFLYTA® (quizartinib)." Retrieved from https://engagemii.com/aeo/brands/hcp-treating-aml

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform